Physician
Dap Health, INC.
Dap Health, INC. was paid $18.74M by Medicaid between Jan 2018 and Dec 2024, across 271 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 33% of everything it billed.
33Billing provider infoDAP HEALTH, INC.
BORREGO SPRINGS, CA 92004
BORREGO SPRINGS, CA 92004
33aNPI1134144165assigned 07/12/2006
33bProvider typeFamily Medicine Physician
28Total paid$18.74M
24GClaims1,802,336
24DCodes billed271
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in California
Rank by total paid#26 of 2,511
Median peer was paid$13K
This provider vs. median1,459×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official STITH, JUDY controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 381,911 | $2.77M | |
| 2019 | 450,853 | $3.36M | |
| 2020 | 263,586 | $3.84M | |
| 2021 | 310,060 | $3.45M | |
| 2022 | 151,803 | $1.40M | |
| 2023 | 164,191 | $2.42M | |
| 2024incomplete | 79,932 | $1.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 33% | 74,238 | 66,508 | $6.13M |
| 00003 | Internal/system code - not a standard HCPCS code | 18% | 12,897 | 9,916 | $3.38M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 535,378 | 486,182 | $2.95M |
| 59425 | 8.7% | 32,388 | 22,934 | $1.63M | |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 6.0% | 25,269 | 19,602 | $1.12M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.3% | 75,468 | 69,026 | $430K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 48,638 | 45,362 | $426K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 8,820 | 8,750 | $231K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.1% | 2,087 | 2,034 | $198K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 15,458 | 14,976 | $168K |
| 99000 | <1% | 191,826 | 177,716 | $159K | |
| 92551 | <1% | 22,085 | 21,226 | $153K |
259 more codes
| 92552 | <1% | 13,711 | $147K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 22,831 | $131K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 17,576 | $103K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 10,100 | $93K |
| G0467 | Community health center visit, returning patient | <1% | 4,246 | $84K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 12,757 | $77K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,475 | $70K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 546 | $68K |
| 90651 | <1% | 3,604 | $64K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 645 | $62K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 65,475 | $53K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 93 | $49K |
| 90686 | <1% | 19,204 | $42K | |
| 90670 | <1% | 4,284 | $42K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 13,878 | $34K |
| 81003 | <1% | 36,313 | $32K | |
| 88141 | <1% | 552 | $28K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 2,909 | $27K |
| 90715 | <1% | 2,394 | $27K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 9,019 | $26K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 678 | $24K |
| 99205 | Prolong outpt/office vis | <1% | 137 | $23K |
| G9012 | Other specified case management service not elsewhere classified | <1% | 6,065 | $23K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,726 | $22K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 4,601 | $22K |
| H2000 | Comprehensive multidisciplinary evaluation | <1% | 240 | $21K |
| 59430 | <1% | 408 | $21K | |
| 86328 | <1% | 515 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,954 | $20K |
| 90739 | <1% | 415 | $19K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 5,923 | $16K |
| 98940 | <1% | 1,954 | $15K | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 1,583 | $15K |
| 81025 | <1% | 8,839 | $10K | |
| 90461 | <1% | 1,916 | $10K | |
| 93000 | <1% | 1,043 | $10K | |
| 99242 | <1% | 219 | $9K | |
| 99381 | <1% | 236 | $9K | |
| 90750 | <1% | 65 | $9K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 2,945 | $9K |
| 90710 | <1% | 1,135 | $8K | |
| 99385 | <1% | 123 | $8K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 843 | $8K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 912 | $7K |
| 90723 | <1% | 1,524 | $6K | |
| 99383 | <1% | 575 | $6K | |
| 90734 | <1% | 1,316 | $6K | |
| 92015 | Determination of refractive state | <1% | 814 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 17,812 | $6K |
| 99201 | <1% | 289 | $6K | |
| 90716 | <1% | 547 | $6K | |
| 85018 | <1% | 24,473 | $5K | |
| 83655 | <1% | 5,044 | $5K | |
| 99401 | <1% | 5,773 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,693 | $5K |
| 90677 | <1% | 463 | $4K | |
| J3490 | Unclassified drugs | <1% | 133 | $4K |
| 11721 | <1% | 444 | $4K | |
| 86580 | <1% | 1,806 | $4K | |
| 90633 | <1% | 3,052 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,379 | $4K |
| 90688 | <1% | 884 | $4K | |
| 90681 | <1% | 555 | $3K | |
| 90707 | <1% | 375 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,037 | $3K |
| 90473 | <1% | 704 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,146 | $3K |
| 99384 | <1% | 83 | $3K | |
| 99460 | <1% | 148 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 206 | $2K |
| 90696 | <1% | 551 | $2K | |
| 81000 | <1% | 850 | $2K | |
| 99173 | <1% | 17,529 | $2K | |
| 0012A | <1% | 130 | $2K | |
| 99382 | <1% | 47 | $2K | |
| 0064A | <1% | 46 | $2K | |
| 90620 | <1% | 420 | $2K | |
| 90648 | <1% | 1,353 | $2K | |
| 0011A | <1% | 90 | $2K | |
| 90697 | <1% | 1,020 | $2K | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 7,732 | $2K |
| 99188 | <1% | 687 | $2K | |
| 20610 | <1% | 44 | $1K | |
| 72081 | <1% | 68 | $1K | |
| 97803 | <1% | 339 | $1K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 300 | $1K |
| 57410 | <1% | 120 | $1K | |
| 90700 | <1% | 532 | $1K | |
| 96160 | <1% | 48,760 | $1K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 175 | $1K |
| 81002 | <1% | 574 | $1K | |
| 90837 | Psychotherapy session, about an hour | <1% | 463 | $1K |
| 90647 | <1% | 1,119 | $790.96 | |
| G9920 | Screening performed and negative | <1% | 1,030 | $754.01 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 90 | $644.39 |
| 72080 | <1% | 33 | $596.64 | |
| 72100 | <1% | 229 | $529.58 | |
| 82948 | <1% | 5,100 | $393.75 | |
| 0031A | <1% | 45 | $369.07 | |
| 73630 | <1% | 267 | $343.98 | |
| 99442 | <1% | 565 | $335.75 | |
| 73562 | <1% | 190 | $331.50 | |
| 90674 | <1% | 14 | $289.64 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 99,772 | $233.75 |
| 99462 | <1% | 28 | $219.92 | |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | <1% | 927 | $215.75 |
| 36415 | Collection of venous blood by venipuncture | <1% | 48,330 | $189.89 |
| 73610 | <1% | 173 | $183.37 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 988 | $150.03 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 57 | $140.16 |
| 73130 | <1% | 82 | $114.94 | |
| 96127 | <1% | 204 | $90.44 | |
| 90713 | <1% | 45 | $89.55 | |
| 73030 | <1% | 38 | $86.30 | |
| 96111 | <1% | 13 | $67.29 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,468 | $66.04 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 117 | $63.21 |
| 90672 | <1% | 115 | $62.06 | |
| 86803 | <1% | 1,005 | $61.33 | |
| 90662 | <1% | 35 | $51.35 | |
| 90619 | <1% | 964 | $42.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,826 | $30.86 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 544 | $29.67 |
| 96150 | <1% | 409 | $17.85 | |
| 84403 | <1% | 215 | $16.83 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,002 | $12.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,441 | $10.21 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,399 | $9.95 |
| 80053 | Comprehensive metabolic panel | <1% | 17,869 | $9.95 |
| 99441 | <1% | 626 | $9.46 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 554 | $8.68 |
| 81001 | <1% | 2,633 | $8.25 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,180 | $6.93 |
| 80061 | Lipid panel | <1% | 15,594 | $6.93 |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | <1% | 868 | $6.92 |
| 85610 | <1% | 59 | $6.92 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 184 | $6.09 |
| 85027 | <1% | 707 | $5.00 | |
| 86592 | <1% | 1,384 | $3.80 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 35 | $2.86 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 214 | $2.09 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 76 | $0.14 |
| S9470 | Nutritional counseling, dietitian visit | <1% | 3,104 | $0.01 |
| 3351F | 0% | 10,672 | $0.00 | |
| 36416 | 0% | 237 | $0.00 | |
| 1000F | 0% | 863 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 8,839 | $0.00 |
| 86695 | 0% | 27 | $0.00 | |
| 82043 | 0% | 1,561 | $0.00 | |
| 3074F | 0% | 823 | $0.00 | |
| 1031F | 0% | 12,548 | $0.00 | |
| 87536 | 0% | 266 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 4,421 | $0.00 |
| 1220F | 0% | 6,987 | $0.00 | |
| 82607 | 0% | 1,444 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 1,730 | $0.00 |
| 99443 | 0% | 90 | $0.00 | |
| 4000F | 0% | 410 | $0.00 | |
| 83550 | 0% | 210 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 0% | 741 | $0.00 |
| 4060F | 0% | 478 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 222 | $0.00 |
| 87340 | 0% | 750 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 106 | $0.00 |
| 82105 | 0% | 58 | $0.00 | |
| Z1034 | 0% | 128 | $0.00 | |
| 86706 | 0% | 321 | $0.00 | |
| 3079F | 0% | 351 | $0.00 | |
| 82670 | 0% | 165 | $0.00 | |
| V5008 | Hearing screening | 0% | 36 | $0.00 |
| 3075F | 0% | 161 | $0.00 | |
| 82728 | 0% | 239 | $0.00 | |
| 2001F | 0% | 339 | $0.00 | |
| 90680 | 0% | 62 | $0.00 | |
| 97802 | 0% | 188 | $0.00 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 17 | $0.00 |
| 86850 | 0% | 58 | $0.00 | |
| 84402 | 0% | 120 | $0.00 | |
| 3080F | 0% | 61 | $0.00 | |
| 84153 | 0% | 216 | $0.00 | |
| J0456 | Injection, azithromycin, 500 mg | 0% | 100 | $0.00 |
| 85652 | 0% | 92 | $0.00 | |
| G9275 | Documentation that patient is a current non-tobacco user | 0% | 125 | $0.00 |
| D1330 | 0% | 13 | $0.00 | |
| 87081 | 0% | 37 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 80 | $0.00 |
| A9150 | Non-prescription drugs | 0% | 16 | $0.00 |
| 3008F | 0% | 13 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 44 | $0.00 |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 0% | 30 | $0.00 |
| 86361 | 0% | 100 | $0.00 | |
| 1034F | 0% | 113 | $0.00 | |
| 91301 | 0% | 73 | $0.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 107 | $0.00 |
| 88150 | 0% | 41 | $0.00 | |
| 84478 | 0% | 47 | $0.00 | |
| 91315 | 0% | 31 | $0.00 | |
| 91305 | 0% | 33 | $0.00 | |
| 91307 | 0% | 26 | $0.00 | |
| 90480 | 0% | 69 | $0.00 | |
| 87070 | 0% | 84 | $0.00 | |
| 94760 | 0% | 12 | $0.00 | |
| 82950 | 0% | 71 | $0.00 | |
| 91319 | 0% | 14 | $0.00 | |
| 86593 | 0% | 12 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 33 | $0.00 |
| Z6410 | 0% | 34 | $0.00 | |
| G9800 | Patients who are identified as having an intolerance or allergy to beta-blocker therapy | 0% | 13 | $0.00 |
| Z1032 | 0% | 13 | $0.00 | |
| 1111F | 0% | 12 | $0.00 | |
| 99001 | 0% | 183 | $0.00 | |
| 80074 | 0% | 721 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 920 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 90 | $0.00 |
| 3078F | 0% | 859 | $0.00 | |
| 83525 | 0% | 201 | $0.00 | |
| 82274 | 0% | 237 | $0.00 | |
| 86765 | 0% | 363 | $0.00 | |
| 84439 | 0% | 995 | $0.00 | |
| 99423 | 0% | 157 | $0.00 | |
| 86038 | 0% | 29 | $0.00 | |
| 90685 | 0% | 41 | $0.00 | |
| 1033F | 0% | 195 | $0.00 | |
| 3077F | 0% | 238 | $0.00 | |
| 86787 | 0% | 349 | $0.00 | |
| 87799 | 0% | 327 | $0.00 | |
| 80076 | 0% | 28 | $0.00 | |
| 87481 | 0% | 184 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 226 | $0.00 |
| 99499 | 0% | 44 | $0.00 | |
| 2028F | 0% | 88 | $0.00 | |
| 4004F | 0% | 784 | $0.00 | |
| 90749 | 0% | 47 | $0.00 | |
| 73140 | 0% | 26 | $0.00 | |
| 86360 | 0% | 33 | $0.00 | |
| 84450 | 0% | 71 | $0.00 | |
| 84460 | 0% | 71 | $0.00 | |
| 69210 | 0% | 76 | $0.00 | |
| 99051 | 0% | 27 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 13 | $0.00 |
| 84481 | 0% | 138 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 41 | $0.00 |
| 0124A | 0% | 28 | $0.00 | |
| 86735 | 0% | 30 | $0.00 | |
| 0054A | 0% | 18 | $0.00 | |
| 87338 | 0% | 45 | $0.00 | |
| 91312 | 0% | 63 | $0.00 | |
| 73110 | 0% | 35 | $0.00 | |
| 91320 | 0% | 14 | $0.00 | |
| 96158 | 0% | 13 | $0.00 | |
| 86480 | 0% | 16 | $0.00 | |
| 90649 | 0% | 21 | $0.00 | |
| 90756 | 0% | 29 | $0.00 | |
| 0502F | 0% | 13 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 12 | $0.00 |
| S0613 | Annual gynecological examination; clinical breast examination without pelvic evaluation | 0% | 12 | $0.00 |
| 90746 | 0% | 13 | $0.00 | |
| S0197 | Prenatal vitamins, 30-day supply | 0% | 17 | $0.00 |
| 92550 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTITH, JUDY (CHIEF ADMINISTRATIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Dap Health, INC. | Desert Hot Springs, CA | $462.99M |
| Dap Health, INC. | El Cajon, CA | $270.21M |
| Dap Health, INC. | Cathedral City, CA | $70.33M |
| Dap Health, INC. | Escondido, CA | $28.57M |
| Dap Health, INC. | Anza, CA | $16.63M |
| Dap Health INC. | Palm Springs, CA | $10.90M |
| Dap Health, INC. | Thermal, CA | $4.18M |
| Dap Health, INC. | Coachella, CA | $4.01M |
| Dap Health, INC. | Desert Hot Springs, CA | $1.57M |
| Dap Health, INC. | La Mesa, CA | $1K |
| Dap Health, INC. | San Jacinto, CA | $705.05 |
| Dap Health, INC. | Vista, CA | $452.70 |
| Dap Health, INC. | Palm Springs, CA | $60.97 |
| Dap Health, INC. | Desert Hot Springs, CA | $0.01 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.